References
- Celli BR, Wedzicha JA. Update on clinical aspects of chronic obstructive pulmonary disease. N Engl J Med. 2019;381(13):1257–1266. DOI:https://doi.org/10.1056/NEJMra1900500
- Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. DOI:https://doi.org/10.1016/S0140-6736(17)31222-9
- Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. DOI:https://doi.org/10.1016/S0140-6736(18)30841-9
- Shim YM, Paige M, Hanna H, et al. Role of LTB4 in the pathogenesis of elastase-induced murine pulmonary emphysema. Am J Physiol Lung Cell Mol Physiol. 2010;299(6):L749–L759. DOI:https://doi.org/10.1152/ajplung.00116.2010
- Snelgrove RJ, Jackson PL, Hardison MT, et al. A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science. 2010;330(6000):90–94. DOI:https://doi.org/10.1126/science.1190594
- Snelgrove RJ. Leukotriene A4 hydrolase: an anti-inflammatory role for a proinflammatory enzyme. Thorax. 2011;66(6):550–551. DOI:https://doi.org/10.1136/thoraxjnl-2011-200234
- Tulah AS, Parker SG, Moffatt MF, et al. The role of ALOX5AP, LTA4H and LTB4R polymorphisms in determining baseline lung function and COPD susceptibility in UK smokers. BMC Med Genet. 2011;12:173. DOI:https://doi.org/10.1186/1471-2350-12-173
- Paige M, Wang K, Burdick M, et al. Role of leukotriene A4 hydrolase aminopeptidase in the pathogenesis of emphysema. J Immunol. 2014;192(11):5059–5068. DOI:https://doi.org/10.4049/jimmunol.1400452
- Wells JM, O’Reilly PJ, Szul T, et al. An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;190(1):51–61. DOI:https://doi.org/10.1164/rccm.201401-0145OC
- Szul T, Castaldi P, Cho MH, et al. Genetic regulation of expression of leukotriene A4 hydrolase. ERJ Open Res. 2016;2(1):00058-2015. DOI:https://doi.org/10.1183/23120541.00058-2015
- Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. DOI:https://doi.org/10.1056/NEJMoa021322
- GOLD Science Committee Members (2020–2021). Global Initiative for Chronic Obstructive Lung Disease. Report: global strategy for prevention, diagnosis and management of COPD; 2021. https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf.